Found: 76
Select item for more details and to access through your institution.
Personalized medicine in oncology: the future is now.
- Published in:
- 2010
- By:
- Publication type:
- review
Statistical and Ethical Issues in the Design and Conduct of Phase I and II Clinical Trials of New Anticancer Agents.
- Published in:
- JNCI: Journal of the National Cancer Institute, 1993, v. 85, n. 20, p. 1637
- By:
- Publication type:
- Article
Phase I trial of granulocyte-macrophage colony-stimulating factor plus high-dose cyclophosphamide given every 2 weeks: a Cancer and Leukemia Group B study.
- Published in:
- 1993
- By:
- Publication type:
- journal article
Clinical Pharmacokinetics of High-Dose Leucovorin Calcium After Intravenous and Oral Administration.
- Published in:
- JNCI: Journal of the National Cancer Institute, 1990, v. 82, n. 17, p. 1411
- By:
- Publication type:
- Article
Response.
- Published in:
- JNCI: Journal of the National Cancer Institute, 1989, v. 81, n. 19, p. 1510
- By:
- Publication type:
- Article
Infertility in Patients With Testicular Cancer: Testis, Tumor, or Treatment?
- Published in:
- JNCI: Journal of the National Cancer Institute, 1989, v. 81, n. 16, p. 1204, doi. 10.1093/jnci/81.16.1204
- By:
- Publication type:
- Article
Hydroxyurea and Etoposide: In Vitro Synergy and Phase I Clinical Trial2.
- Published in:
- JNCI: Journal of the National Cancer Institute, 1988, v. 80, n. 17, p. 1412, doi. 10.1093/jnci/80.17.1412
- By:
- Publication type:
- Article
Effect of Mopidamol on Survival in Carcinoma of the Lung and Colon: Final Report of Veterans Administration Cooperative Study No. 188.
- Published in:
- JNCI: Journal of the National Cancer Institute, 1988, v. 80, n. 2, p. 90
- By:
- Publication type:
- Article
Gonadal dysfunction in patients receiving chemotherapy for cancer.
- Published in:
- 1980
- By:
- Publication type:
- journal article
Hypomagnesemia and Renal Magnesium Wasting in Patients Receiving Cisplatin.
- Published in:
- 1979
- By:
- Publication type:
- Case Study
Identification of a central network hub of key prognostic genes based on correlation between transcriptomics and survival in patients with metastatic solid tumors.
- Published in:
- Therapeutic Advances in Medical Oncology, 2024, p. 1, doi. 10.1177/17588359241289200
- By:
- Publication type:
- Article
A transcriptomics approach to expand therapeutic options and optimize clinical trials in oncology.
- Published in:
- Therapeutic Advances in Medical Oncology, 2023, p. 1, doi. 10.1177/17588359231156382
- By:
- Publication type:
- Article
Cisplatin, 5-fluorouracil, and high-dose oral leucovorin for advanced head and neck cancer.
- Published in:
- Cancer (0008543X), 1989, v. 63, n. S6, p. 1048, doi. 10.1002/1097-0142(19890315)63:6+<1048::AID-CNCR2820631311>3.0.CO;2-#
- By:
- Publication type:
- Article
Clinical pharmacology of the stereoisomers of leucovorin during repeated oral dosing.
- Published in:
- Cancer (0008543X), 1989, v. 63, n. S6, p. 1018, doi. 10.1002/1097-0142(19890315)63:6+<1018::AID-CNCR2820631305>3.0.CO;2-S
- By:
- Publication type:
- Article
A randomized study of inpatient versus outpatient continuous infusion chemotherapy for patients with locally advanced head and neck cancer.
- Published in:
- 1989
- By:
- Publication type:
- journal article
What can heart failure trialists learn from oncology trialists?
- Published in:
- European Heart Journal, 2021, v. 42, n. 24, p. 2373, doi. 10.1093/eurheartj/ehab236
- By:
- Publication type:
- Article
A phase I trial of pharmacologic modulation of irinotecan with cyclosporine and phenobarbital<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 2004, v. 76, n. 5, p. 490, doi. 10.1016/j.clpt.2004.07.016
- By:
- Publication type:
- Article
Etoposide combined with interferon alfa-2b: Novel exploitation of established etoposide pharmacokinetics and pharmacodynamics<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 1996, v. 59, n. 3, p. 349, doi. 10.1016/S0009-9236(96)80013-0
- By:
- Publication type:
- Article
Modulation of vinblastine resistance with cyclosporine: A phase I study.
- Published in:
- Clinical Pharmacology & Therapeutics, 1993, v. 54, n. 4, p. 421, doi. 10.1038/clpt.1993.169
- By:
- Publication type:
- Article
Paradoxical relationship between acetylator phenotype and amonafide toxicity.
- Published in:
- Clinical Pharmacology & Therapeutics, 1991, v. 50, n. 5, p. 573, doi. 10.1038/clpt.1991.183
- By:
- Publication type:
- Article
Adaptive control of etoposide administration: Impact of interpatient pharmacodynamic variability.
- Published in:
- Clinical Pharmacology & Therapeutics, 1989, v. 45, n. 3, p. 226, doi. 10.1038/clpt.1989.22
- By:
- Publication type:
- Article
Targeted Therapy for Cancer: Asking the Right Questions.
- Published in:
- Oncology (08909091), 2012, v. 26, n. 10, p. 947
- By:
- Publication type:
- Article
Measuring Disease-Free Survival and Cancer Relapse Using Medicare Claims From CALGB Breast Cancer Trial Participants (Companion to 9344).
- Published in:
- JNCI: Journal of the National Cancer Institute, 2006, v. 98, n. 18, p. 1335, doi. 10.1093/jnci/djj363
- By:
- Publication type:
- Article
Criterion validity of Medicare chemotherapy claims in Cancer and Leukemia Group B breast and lung cancer trial participants.
- Published in:
- 2005
- By:
- Publication type:
- journal article
Oncology Physician and Nurse Practices and Attitudes Regarding Offering Clinical Trial Results To Study Participants.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2004, v. 96, n. 8, p. 629, doi. 10.1093/jnci/djh096
- By:
- Publication type:
- Article
Silence is golden: gene hypermethylation and survival in large-cell lymphoma.
- Published in:
- 2002
- By:
- Publication type:
- commentary
'Strategic' development of precision cancer medicine in the United States.
- Published in:
- Molecular Oncology, 2021, v. 15, n. 7, p. 1747, doi. 10.1002/1878-0261.13023
- By:
- Publication type:
- Article
Prognostic factors for survival in patients treated in phase I clinical trials.
- Published in:
- 1994
- By:
- Publication type:
- journal article
A phase I study of intermittent infusion cladribine in patients with solid tumors.
- Published in:
- 1994
- By:
- Publication type:
- journal article
Cytosine arabinoside and cisplatin for advanced breast cancer. A phase II study of the Cancer and Leukemia Group B.
- Published in:
- 1991
- By:
- Publication type:
- journal article
THE SYNTHESIS AND RETENTION OF METHOTREXATE POLYGLUTAMATES IN CULTURED HUMAN BREAST CANCER CELLS.
- Published in:
- Annals of the New York Academy of Sciences, 1982, v. 397, n. 1, p. 184, doi. 10.1111/j.1749-6632.1982.tb43426.x
- By:
- Publication type:
- Article
A WIN Consortium phase I study exploring avelumab, palbociclib, and axitinib in advanced non‐small cell lung cancer.
- Published in:
- Cancer Medicine, 2022, v. 11, n. 14, p. 2790, doi. 10.1002/cam4.4635
- By:
- Publication type:
- Article
Highlights from the 2015 WIN Symposium: novel targets, innovative agents, and advanced technologies--a WINning strategy?
- Published in:
- 2015
- By:
- Publication type:
- Proceeding
Highlights from the 2013 WIN Symposium: personalised cancer therapy from innovation to implementation.
- Published in:
- Ecancermedicalscience, 2013, v. 7, n. 334-360, p. 1, doi. 10.3332/ecancer.2013.344
- By:
- Publication type:
- Article
Phase I study to evaluate multiple regimens of intravenous 5-fluorouracil administered in combination with weekly gemcitabine in patients with advanced solid tumors: a potential broadly active regimen for advanced solid tumor malignancies.
- Published in:
- 2001
- By:
- Publication type:
- journal article
Phase II study of oral eniluracil, 5-fluorouracil, and leucovorin in patients with advanced colorectal carcinoma.
- Published in:
- 2001
- By:
- Publication type:
- journal article
Pharmacokinetic modulation of oral etoposide by ketoconazole in patients with advanced cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2007, v. 60, n. 6, p. 811, doi. 10.1007/s00280-007-0428-5
- By:
- Publication type:
- Article
Estimation of the effect of food on the disposition of oral 5-fluorouracil in combination with eniluracil.
- Published in:
- 2002
- By:
- Publication type:
- journal article
The International Collaboration for Cancer Classification and Research.
- Published in:
- International Journal of Cancer, 2021, v. 148, n. 3, p. 560, doi. 10.1002/ijc.33260
- By:
- Publication type:
- Article
Breaking a Vicious Cycle.
- Published in:
- Science Translational Medicine, 2013, v. 5, n. 196, p. 1, doi. 10.1126/scitranslmed.3005950
- By:
- Publication type:
- Article
Accrual to Cancer Clinical Trials in the Era of Molecular Medicine.
- Published in:
- Science Translational Medicine, 2011, v. 3, n. 75, p. 1, doi. 10.1126/scitranslmed.3001712
- By:
- Publication type:
- Article
Refocusing the War on Cancer: The Critical Role of Personalized Treatment.
- Published in:
- Science Translational Medicine, 2010, v. 2, n. 28, p. 1, doi. 10.1126/scitranslmed.3000643
- By:
- Publication type:
- Article
Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic Colorectal Cancer: A Randomized Clinical Trial.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Development and Validation of a Natural Language Processing Tool to Generate the CONSORT Reporting Checklist for Randomized Clinical Trials.
- Published in:
- JAMA Network Open, 2020, v. 3, n. 10, p. e2014661, doi. 10.1001/jamanetworkopen.2020.14661
- By:
- Publication type:
- Article
Olaparib Extends Survival by >1 Year in Women with Relapsed Ovarian Cancer and BRCA Mutation.
- Published in:
- Journal of Oncology Navigation & Survivorship, 2020, v. 11, n. 10, p. 376
- By:
- Publication type:
- Article
Adjuvant Osimertinib a "Home Run" in Patients with Localized NSCLC.
- Published in:
- Journal of Oncology Navigation & Survivorship, 2020, v. 11, n. 10, p. 359
- By:
- Publication type:
- Article
Cetuximab in Patients with Breast Cancer, Non-Small Cell Lung Cancer, and Ovarian Cancer Without KRAS, NRAS, or BRAF Mutations: Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.
- Published in:
- Targeted Oncology, 2020, v. 15, n. 6, p. 733, doi. 10.1007/s11523-020-00753-7
- By:
- Publication type:
- Article
Sunitinib in Patients with Metastatic Colorectal Cancer (mCRC) with FLT-3 Amplification: Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.
- Published in:
- Targeted Oncology, 2020, v. 15, n. 6, p. 743, doi. 10.1007/s11523-020-00752-8
- By:
- Publication type:
- Article
Patient advocates' role in clinical trials.
- Published in:
- Cancer (0008543X), 2012, v. 118, n. 19, p. 4801, doi. 10.1002/cncr.27485
- By:
- Publication type:
- Article
Challenges and Opportunities to Updating Prescribing Information for Longstanding Oncology Drugs.
- Published in:
- Oncologist, 2020, v. 25, n. 3, p. e405, doi. 10.1634/theoncologist.2019-0698
- By:
- Publication type:
- Article